logo

Charting the Course: EyePoint Pharmaceuticals Inc’s EYPT Stock Prospects

CSCO Stock

The stock market performance of EyePoint Pharmaceuticals Inc has been very steady. Over the last year, the company’s stock hit its highest at $30.99 on 02/08/24, while the lowest price during the same time frame was $5.67, recorded on 10/30/23.

52-week price history of EYPT Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. EyePoint Pharmaceuticals Inc’s current trading price is -63.86% away from its 52-week high, while its distance from the 52-week low is 97.53%. The stock’s price range during this period has fluctuated between $5.67 and $30.99. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 9.65 million for the day, which was evidently higher than the average daily volume of 1.0 million over the last three months.

Financial Performance and Market Capitalization

EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly decline of -59.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 558.10M and boasts a workforce of 121 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 22.84, with a change in price of -8.77. Similarly, EyePoint Pharmaceuticals Inc recorded 1,105,931 in trading volume during the last 100 days, posting a change of -43.92%.

EYPT Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EYPT stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.

EYPT Stock Stochastic Average

EyePoint Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 0.77%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 1.11%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 35.86% and 39.60%, respectively.

EYPT Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -51.54%. However, over the past six months, we’ve seen a weaker performance of 53.64%. The price of EYPT leaped by -44.77% over the last 30 days. And in the last five days, it has fallen by -36.47%.

Most Popular